Understanding how disrupted lipid metabolism affects Alzheimer's disease

Disrupted Lipid Metabolism in Alzheimer's Disease

NIH-funded research University of Arizona · NIH-10884782

This study is looking at how the way our brain cells handle fats might affect Alzheimer's disease, with the hope of finding new ways to help people manage their symptoms and improve their brain health.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Arizona NIH-funded
Lab location1 site (Tucson, United States)
Project IDNIH-10884782 on NIH RePORTER

What this research studies

This research investigates the role of lipid metabolism in Alzheimer's disease, focusing on how changes in fatty acid processing in brain cells, particularly astrocytes, may contribute to the onset and progression of the disease. By examining the mechanisms behind lipid dysregulation, the study aims to uncover potential pathways that lead to neuroinflammation and cognitive decline associated with Alzheimer's. Patients may benefit from insights gained into how lipid metabolism influences their condition, potentially leading to new therapeutic strategies.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk due to genetic or lifestyle factors.

Not a fit: Patients with other forms of dementia unrelated to lipid metabolism may not receive benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments targeting lipid metabolism to slow or prevent the progression of Alzheimer's disease.

How similar studies have performed: Previous research has indicated that targeting lipid metabolism may have therapeutic potential in neurodegenerative diseases, suggesting a promising avenue for further exploration.

Where this research is happening

Tucson, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.